EUVIMEDOpdag EUVIMED
Open access

Combinatorial action of regulatory systems generates colistin heteroresistance

Jacob E Choby iD, Emily K Crispell, Muqing Ma iD, Linda M Vu iD, Mary-Kate Key iD, Robert K Ernst iD, Minsu Kim iD, David S Weiss iD

Science Advances · 2026

DOI: 10.1126/sciadv.aec7052 ↗

At a glance

Journal article in Science Advances, 2026. Written by Jacob E Choby and 7 co-authors. Institution: Emory Antibiotic Resistance Center, Atlanta, GA 30322, USA. Major MEDLINE topics: Colistin, Drug Resistance, Bacterial, Anti-Bacterial Agents. 64 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, NIDDK NIH HHS, NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

The mechanism by which phenotypic heterogeneity is generated within a bacterial population and leads to colistin heteroresistance has been unclear. Heteroresistance is a form of antibiotic resistance in which a minor subpopulation of resistant cells coexists with a majority susceptible population. Colistin heteroresistance is common among Enterobacter isolates, threatens its utility as a therapeutic, and has become a model to study the fundamental bases of heteroresistance. Here, we identify the sigma factor σ E as the source of heterogeneity in colistin resistance. Single-cell tracking revealed that σ E is active in 1% of the population, and only those cells survive colistin exposure. However, σ E expression and heterogeneity were insufficient for survival, as a mutant lacking the PhoPQ system controlling lipid A modifications necessary for colistin resistance retained heterogeneity but lost resistance. These findings lead to a paradigm in heteroresistance; the combinatorial action of regulatory systems, encompassing a heterogeneity generator and a distinct resistance generator, gives rise to colistin heteroresistance.

Subjects

MeSH terms (MEDLINE)

ColistinDrug Resistance, BacterialAnti-Bacterial AgentsSigma FactorBacterial ProteinsGene Expression Regulation, BacterialMicrobial Sensitivity Tests

Substances

ColistinSigma FactorAnti-Bacterial AgentsBacterial Proteins

Authors and institutions

  • Emory Antibiotic Resistance Center, Atlanta, GA 30322, USA.
  • Emory Vaccine Center, Atlanta, GA 30322, USA.
  • Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.
  • Department of Physics, Emory University, Atlanta, GA 30322, USA.
  • Department of Microbial Pathogenesis, University of Maryland-Baltimore, Baltimore, MD 21201, USA.
  • Graduate Division of Biological and Biomedical Sciences, Emory University, Atlanta, GA 30322, USA.

ORCID profiles: Jacob E Choby, Muqing Ma, Linda M Vu, Mary-Kate Key, Robert K Ernst, Minsu Kim, David S Weiss

Funding

  • NIAID NIH HHS
  • NIDDK NIH HHS
  • NIH HHS
  • National Institutes of Health
  • NIH Office of the Director
  • Burroughs Wellcome Fund
  • Cystic Fibrosis Foundation

Cite

APA

Choby, J. E., Crispell, E. K., Ma, M., Vu, L. M., Key, M. K., Ernst, R. K., Kim, M., & Weiss, D. S. (2026). Combinatorial action of regulatory systems generates colistin heteroresistance. Science Advances. https://doi.org/10.1126/sciadv.aec7052

Vancouver

Choby JE, Crispell EK, Ma M, Vu LM, Key MK, Ernst RK, et al. Combinatorial action of regulatory systems generates colistin heteroresistance. Science Advances. 2026. doi:10.1126/sciadv.aec7052

BibTeX
@article{Choby2026,
  author = {Choby, Jacob E and Crispell, Emily K and Ma, Muqing and Vu, Linda M and Key, Mary-Kate and Ernst, Robert K and Kim, Minsu and Weiss, David S},
  title = {Combinatorial action of regulatory systems generates colistin heteroresistance},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aec7052}
}
Start for free →